Fu, Siqing <br/><br/>
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.  [electronic resource] 

 -  Cancer biology & therapy  Sep 2012 
 - 1034-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.21045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinase B<br/>Aurora Kinases<br/>Carboplatin--administration & dosage<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Down-Regulation--drug effects<br/>Drug Synergism<br/>Female<br/>Histones--genetics<br/>Humans<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Piperazines--administration & dosage<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors